In vivo imaging of prostate cancer involving bone in a mouse model

V Kundra, CS Ng, J Ma, JA Bankson, RE Price… - The …, 2007 - Wiley Online Library
V Kundra, CS Ng, J Ma, JA Bankson, RE Price, DD Cody, KA Do, L Han, NM Navone
The Prostate, 2007Wiley Online Library
Background We compared the abilities of clinically relevant imaging modalities to quantify
prostate cancer involving bone in a mouse model. Such non‐invasive methods are needed
pre‐clinically to understand tumor biology and to evaluate therapy. Methods Human prostate
cancer cells (MDA PCa 2b) or vehicle were injected into the right or left femur of SCID mice
(n= 8). Radiography, computed tomography, and magnetic resonance imaging were
performed 5 and 8 weeks later (n= 7). Bone scintigraphy (n= 6) was also performed at week …
Background
We compared the abilities of clinically relevant imaging modalities to quantify prostate cancer involving bone in a mouse model. Such non‐invasive methods are needed pre‐clinically to understand tumor biology and to evaluate therapy.
Methods
Human prostate cancer cells (MDA PCa 2b) or vehicle were injected into the right or left femur of SCID mice (n = 8). Radiography, computed tomography, and magnetic resonance imaging were performed 5 and 8 weeks later (n = 7). Bone scintigraphy (n = 6) was also performed at week 8. Imaging findings were compared with histology and correlated with contemporaneous serum prostate‐specific antigen levels.
Results
Among the modalities evaluated, only MR imaging delineated prostate tumors involving bone. Tumor volume assessed by MR imaging correlated with PSA levels (R2 = 0.87, P < 0.001). MR imaging of tumors corresponded with histology. Imaging of mineralized bone by CT corresponded with histology.
Conclusion
In a mouse model, prostate tumors involving bone can be quantified using MR imaging. Prostate 67:50–60, 2007. © 2006 Wiley‐Liss, Inc.
Wiley Online Library